Shandong Jincheng Pharmaceutical Co. Ltd. A | Ownership
Companies that own Shandong Jincheng Pharmaceutical Co. Ltd. A
Taikang Asset Management Co., Ltd.
7,559,018
2.29%
5,978,048
0.37%
09/30/2017
China Investment Corp. (Investment Management)
3,278,400
0.99%
0
0.02%
09/30/2017
China Foreign Economy & Trade Trust Co., Ltd.
1,904,100
0.57%
598,500
0.46%
09/30/2017
China Minsheng Trust Co., Ltd.
1,823,800
0.55%
1,823,800
0.69%
09/30/2017
China Life Asset Management Co., Ltd.
1,699,902
0.51%
1,699,902
0.04%
09/30/2017
Huatai-PineBridge Fund Management Co., Ltd.
501,231
0.15%
468,971
0.02%
12/31/2017
Galaxy Asset Management Co., Ltd.
256,900
0.08%
232,945
0.03%
12/31/2017
Beixin Ruifeng Fund Management Co. Ltd.
172,680
0.05%
32,680
0.01%
12/31/2017
Harfor Fund Management Co., Ltd.
84,500
0.03%
84,500
0.03%
12/31/2017
CR Yuanta Fund Management Co.,Ltd
71,900
0.02%
71,900
0.08%
12/31/2017
| Address |
Zichuan Economic Development Zone
Zibo Shandong 255100
China
|
|
Employees
|
- |
| Website |
http://www.jinchengpharm.com |
| Updated |
07/08/2019 |
| Shandong Jincheng Pharmaceutical Group Co., Ltd. engages in the research and development, production and sale of III and IV cephalosporin intermediates and bio-pharmaceuticals. Its products are categorized into the following divisions: Characteristic Bulk Drugs, Pharmaceutical Intermediates, and Fine Chemicals. The company was founded by Hong Fu Zhao on January 12, 2004 and is headquartered in Zibo, China. |
